Sigachi Industries per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹0.67−₹2.14₹2.06₹1.81₹14.16
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹0.67−₹2.14₹2.06₹1.54₹14.16
₹13.65₹13.65₹15.72₹13.09₹87.29
₹12.32₹12.50₹12.78₹12.16₹98.25
—₹0.11₹0.70₹0.39₹9.44
−₹0.96−₹0.96−₹0.43−₹2.20−₹23.32
—₹0.10₹0.09₹0.09₹1.00
38.238.238.232.83.1
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SIGACHI₹26.54

Sigachi Industries Limited

· Pharma & Health
₹ CrorePeersLINCOLNTHEMISMEDBAJAJHCAREAMRUTANJANJAGSNPHARMWANBURYNGLFINEMcap ₹1,014 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS14.161.812.06-2.140.67
Diluted EPS14.161.542.06-2.140.67
Book Value per Share87.2913.0915.7213.6513.65
Revenue per Share98.2512.1612.7812.5012.32
Cash Flow per Share9.440.390.700.11—
Free Cash Flow per Share-23.32-2.20-0.43-0.96-0.96
Dividends per Share1.000.090.090.10—
Shares Outstanding (cr)3.132.838.238.238.2
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.